Page last updated: 2024-11-12

phaseolotoxin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

phaseolotoxin: exotoxin from Pseudomonas sp.; cleavage of C terminal alanine and homoarginine from phaseolotoxin leaves octicidine [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

phaseolotoxin : A tripeptide resulting from the formal condensation of the carboxy group of N(5)-[amino(sulfoamino)phosphoryl]-L-ornithine with the N-terminal amino group of L-alanyl-L-arginine. A toxin produced by cultured Pseudomonas syringae, the causal agent of halo blight disease in bean plants. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID9936860
MeSH IDM0314460

Synonyms (7)

Synonym
n5-[amino(sulfoamino)phosphinyl]-l-ornithyl-l-alanyl-n6-(aminoiminomethyl)-l-lysine
phaseolotoxin
C08440 ,
qyf9h833x4 ,
AKOS030531674
l-lysine, n5-(amino(sulfoamino)phosphinyl)-l-ornithyl-l-alanyl-n6-(aminoiminomethyl)-
(2s)-2-((2s)-2-((2s)-2-amino-5-((amino(sulfoamino)phosphoryl)amino)pentanamido)propanamido)-6-guanidinohexanoicacid

Research Excerpts

Overview

phaseolotoxin (PT) is a non-host specific phytotoxin produced by the plant pathogenic bacterium Pseudomonas syringae (P.S.) pv. PT is an effective inhibitor of ornithine carbamoyltransferase (OCTase) activity.

ExcerptReferenceRelevance
"Phaseolotoxin is an effective inhibitor of ornithine carbamoyltransferase (OCTase) activity from plant, mammalian and bacterial sources and causes a phenotypic requirement for arginine."( Expression of the gene for resistance to phaseolotoxin (argK) depends on the activity of genes phtABC in Pseudomonas syringae pv. phaseolicola.
Aguilera, S; Alvarez-Morales, A; Bravo, J; De la Torre-Zavala, S; Hernández-Flores, JL; Murillo, J, 2012
)
1.37
"Phaseolotoxin (PT) is a non-host specific phytotoxin produced by the plant pathogenic bacterium Pseudomonas syringae (P.s.) pv. "( Inhibitory effects of phaseolotoxin on proliferation of leukemia cells HL-60, K-562 and L1210 and pancreatic cells RIN-m5F.
Bachmann, AS; Patil, SS; Ratnapala, L; Xu, R, 2004
)
2.08
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (47)

TimeframeStudies, This Drug (%)All Drugs %
pre-199010 (21.28)18.7374
1990's12 (25.53)18.2507
2000's14 (29.79)29.6817
2010's10 (21.28)24.3611
2020's1 (2.13)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 26.37

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index26.37 (24.57)
Research Supply Index3.93 (2.92)
Research Growth Index4.51 (4.65)
Search Engine Demand Index31.58 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (26.37)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (4.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other48 (96.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]